Patent Assignment
Reel/Frame 025980/0024
Release of Security Interest
Recorded: 2011-03-18
Pages: 10
Assignor
U.S. HEALTHCARE, LLC (AS ADMINISTRATIVE AND COLLATERAL AGENT)
Executed: 2011-03-17
Assignee
DRUGTECH CORPORATION
300 DELAWARE AVENUE, SUITE 1270, WILMINGTON, DELAWARE, 19801
Covered Properties
(67)
Endometriosis Treatment
PCT:
PCT/US2008/060869 ↗
Dosage Form and Method of Use
PCT:
PCT/US2008/071900 ↗
Anti-Proliferative Combinations
PCT:
PCT/US2008/074479 ↗
Extrnded Release Pharmaceutical Formulations
Patent:
5,133,974 →
Application:
07/469,210 →
Particle Enrobing Process and Apparatus
Patent:
5,061,520 →
Application:
07/593,099 →
Vaginal Delivery System
Patent:
5,266,329 →
Application:
07/798,873 →
Oral Once-Per-Day Formulation Which Does Not Induce Tolerance
Patent:
5,296,232 →
Application:
07/882,537 →
Extended Release Pharmaceutical Formulations
Patent:
5,445,829 →
Application:
07/898,539 →
Long Acting Gi and Esophageal Protectant
Patent:
5,554,379 →
Application:
08/262,254 →
Multi-Vitamin and Mineral Supplement for Pregnant Women
Patent:
5,494,678 →
Application:
08/410,733 →
Long Acting Gi and Esophageal Protectant
Patent:
5,670,163 →
Application:
08/432,805 →
Bioadhesive Pharmaceutical Delivery System
Patent:
5,554,380 →
Application:
08/441,297 →
Multi-Vitamin and Mineral Supplements for Women
Patent:
5,869,084 →
Application:
08/474,071 →
Multi- Vitamin and Mineral Supplement for Pregnant Women
Patent:
6,228,388 →
Application:
08/852,600 →
Long Acting Gi and Esophageal Protectant
Patent:
5,858,391 →
Application:
08/864,109 →
Pharmaceutical Preparations and Methods for Their Administration
Patent:
5,993,856 →
Application:
08/971,346 →
Vitamin/Nutrient Dosage Regimentation
Patent:
6,696,083 →
Application:
09/016,786 →
Maximizing Effectiveness of Substances Used to Improve Health and Well Being
Patent:
5,945,123 →
Application:
09/053,487 →
Folic Acid Supplement
Patent:
6,261,600 →
Application:
09/303,000 →
Dietary Supplement
Patent:
6,569,857 →
Application:
09/303,689 →
Anti-Nausea Compositions and Methods
Patent:
6,197,329 →
Application:
09/303,690 →
Maximizing Effectiveness of Substances Used to Improve Health and Well Being
Patent:
6,214,379 →
Application:
09/323,158 →
Nutritional Supplements
Patent:
6,258,846 →
Application:
09/323,159 →
Pharmaceutical Preparations and Methods for Their Regional Administration
Patent:
6,416,778 →
Application:
09/355,213 →
Strip Pack
Patent:
6,375,956 →
Application:
09/358,540 →
Formulation for Menopausal Women
Patent:
6,479,545 →
Application:
09/409,059 →
Multi-Vitamin and Mineral Supplements for Women
Patent:
6,488,956 →
Application:
09/448,744 →
Nutritional Composition
Patent:
6,352,713 →
Application:
09/451,849 →
Composition with Sustained Release of Levodopa and Carbidopa
Nutritional Supplements
Mineral Supplement
Bioadhesive Drug Delivery System
Formulation for Menopausal Women
Pharmaceutical Preparations and Methods for Their Regional Administration
Nutritional Supplements
Gellan gum based oral controlled release dosage forms-a novel platform technology for gastric retention
Application:
10/565,593 →
Publication:
US 2006/0177497
Rapidly Disintegrable Tablets
Patent:
7,282,217 →
Application:
10/929,856 →
Pharmaceutical delivery system
Application:
10/944,416 →
Publication:
US 2005/0095245
Compositions including iron
Application:
11/020,801 →
Publication:
US 2006/0134227
Cardiovascular compositions
Application:
11/021,282 →
Publication:
US 2006/0135610
Composition for topical treatment of mixed vaginal infections
Application:
11/326,979 →
Publication:
US 2006/0140990
Therapeutic methods of using estrogen compositions
Application:
11/502,066 →
Publication:
US 2008/0085877
Estrogen compositions and therapeutic methods of use thereof
Application:
11/502,253 →
Publication:
US 2007/0036848
Delivery System
Composition and Method of Use Thereof
Application:
11/617,180 →
Publication:
US 2007/0224226
Drug Delivery System
Application:
11/617,199 →
Publication:
US 2007/0154516
Methods for Determining Absorption of Cobalamin or Analogues Thereof
Intravaginal Medicament Applicators
Application:
11/684,009 →
Publication:
US 2007/0225655
Methods and Compositions for Enhancing Iron Absorption
Application:
11/793,517 →
Publication:
US 2009/0028962
Sustained-Release Composition and Method of Use Thereof
Application:
11/850,063 →
Publication:
US 2008/0139655
Rapidly Disintegrable Tablets
Patent:
7,425,341 →
Application:
11/853,355 →
Topical Therapies for Oral Mucositis and Other Conditions
Application:
11/865,476 →
Publication:
US 2008/0299050
Compositions and Methods for Treating Seizures
Application:
11/950,989 →
Publication:
US 2008/0138383
Compositions for Improving Gastrointestinal Nutrient and Drug Absorption
Application:
12/027,538 →
Publication:
US 2008/0193531
Endometriosis Treatment
Application:
12/105,878 →
Publication:
US 2008/0287408
Controlled Release Dopamine Agonist Compositions
Application:
12/126,575 →
Publication:
US 2008/0299189
Dosage Form and Method of Use
Application:
12/183,989 →
Publication:
US 2009/0035370
Compositions Including Iron
Application:
12/195,170 →
Publication:
US 2009/0035385
Anti-Proliferative Combinations
Application:
12/199,503 →
Publication:
US 2009/0068190
Transdermal, Alcohol-Free, Pharmaceutical Compositions
Application:
12/209,864 →
Publication:
US 2009/0098069
Transdermal Hormone Spray
Application:
12/209,961 →
Publication:
US 2009/0075963
Nutritional Supplements
Application:
12/260,794 →
Publication:
US 2009/0270503
Formulation for Menopausal Women
Application:
12/271,500 →
Publication:
US 2009/0068289
Transgenic Plants Expressing Cobalamin Binding Proteins
Nutritional Formulations
Application:
12/578,735 →
Publication:
US 2010/0129496
Methods of Administering Compositions Including Iron
Application:
12/891,376 →
Publication:
US 2011/0015150
Methods for Reducing the Occurrence of Preterm Delivery and Other Pregnancy-Related Conditions
Application:
61/289,572 →
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Mar 18, 2011
From: U.S. HEALTHCARE I, LLC (AS ADMINISTRATIVE AND COLLATERAL AGENT)
To: DRUGTECH CORPORATION
Reel/Frame 025981/0934 →
Security Agreement
Mar 18, 2011
From: DRUGTECH CORPORATION
To: WILMINGTON TRUST FSB (AS COLLATERAL AGENT)
Reel/Frame 025981/0068 →
Security Agreement
Sep 17, 2013
From: DRUGTECH CORPORATION
To: LAW DEBENTURE TRUST COMPANY OF NEW YORK, AS AGENT
Reel/Frame 031226/0883 →
Change of Name
Jul 9, 2014
From: DRUGTECH CORPORATION
To: LUMARA HEALTH IP LTD.
Reel/Frame 033282/0265 →
Assignment of Assignor's Interest
Jul 9, 2014
From: KV PHARMACEUTICAL COMPANY
To: DRUGTECH CORPORATION
Reel/Frame 033269/0474 →
Assignment of Assignor's Interest
Jul 9, 2014
From: HERMELIN, VICTOR M.
To: KV PHARMACEUTICAL COMPANY
Reel/Frame 033269/0393 →
Release of Security Interests in Intellectual Property
Oct 20, 2014
From: LAW DEBENTURE TRUST COMPANY OF NEW YORK
To: K-V PHARMACEUTICAL COMPANY
Reel/Frame 034018/0040 →
Security Interest
Nov 12, 2014
From: LUMARA HEALTH IP LTD
To: JEFFERIES FINANCE LLC
Reel/Frame 034156/0243 →
Assignment of Assignor's Interest
Nov 25, 2014
From: LUMARA HEALTH IP LTD
To: ELAN PHARMA INTERNATIONAL LTD
Reel/Frame 034470/0835 →
Security Interest
Sep 25, 2015
From: LUMARA HEALTH IP LTD.
To: JEFFERIES FINANCE LLC
Reel/Frame 036653/0138 →
Change of Name
Sep 30, 2015
From: DRUGTECH CORPORATION
To: LUMARA HEALTH IP LTD.
Reel/Frame 036725/0894 →
Release of Security Interest
Oct 1, 2015
From: WILLMINGTON TRUST, NATIONAL ASSOCIATION
To: LUMARA HEALTH IP LTD
Reel/Frame 036704/0822 →
Release of Security Interest
Oct 9, 2015
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: LUMARA HEALTH IP LTD.
Reel/Frame 036763/0475 →
Change of Name
Dec 1, 2016
From: PERRIGO PHARMA INTERNATIONAL LIMITED
To: PERRIGO PHARMA INTERNATIONAL DESIGNATED ACTIVITY COMPANY
Reel/Frame 040780/0943 →
Change of Name
Dec 1, 2016
From: ELAN PHARMA INTERNATIONAL LTD.
To: PERRIGO PHARMA INTERNATIONAL LIMITED
Reel/Frame 040478/0926 →
Release of Security Interest
May 15, 2017
From: JEFFERIES FINANCE LLC
To: LUMARA HEALTH IP LTD.
Reel/Frame 042461/0626 →
Change of Name
Dec 27, 2017
From: LUMARA HEALTH IP LTD.
To: AMAG PHARMACEUTICALS IP, LTD.
Reel/Frame 044961/0232 →
Merger and Change of Name
Jan 3, 2018
From: AMAG PHARMACEUTICALS IP, LTD.; AMAG PHARMA USA, INC.
To: AMAG PHARMA USA, INC.
Reel/Frame 044523/0160 →
Security Agreement
Jul 7, 2021
From: PADAGIS US LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 056773/0863 →
Assignment of Assignor's Interest
Jul 13, 2021
From: PERRIGO PHARMA INTERNATIONAL DESIGNATED ACTIVITY COMPANY
To: PERRIGO COMPANY
Reel/Frame 056831/0001 →
Assignment of Assignor's Interest
Jul 14, 2021
From: PERRIGO COMPANY
To: PADAGIS US LLC
Reel/Frame 056851/0871 →